Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karst Y Heida

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 8, 2017
Cardiovascular biochemical risk factors among women with spontaneous preterm deliveryKarst Y Heida, Marlies A Kampman, Arie Franx, et al.
Congenital Heart Disease|August 22, 2008
Menstrual cycle and its disorders in women with congenital heart diseaseWillem Drenthen, Elke S Hoendermis, Philip Moons, et al.
American Journal of Obstetrics and Gynecology|December 3, 2014
Evaluation of strategies regarding management of imminent preterm delivery before 32 weeks of gestation: a regional cohort study among 1375 women in the NetherlandsMerel Boesveld, Martijn A Oudijk, Steven V Koenen, et al.
Journal of Clinical Medicine|October 28, 2023
Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort StudySapthami Nadesapillai, Femke Mol, Simone L Broer, et al.
BMC Pregnancy and Childbirth|March 5, 2014
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)Elvira Og van Vliet, Ewoud Schuit, Karst Y Heida, et al.
Lancet (London, England)|March 6, 2016
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trialElvira O G van Vliet, Tobias A J Nijman, Ewoud Schuit, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 8, 2017
Cardiovascular biochemical risk factors among women with spontaneous preterm deliveryKarst Y Heida, Marlies A Kampman, Arie Franx, et al.
Congenital Heart Disease|August 22, 2008
Menstrual cycle and its disorders in women with congenital heart diseaseWillem Drenthen, Elke S Hoendermis, Philip Moons, et al.
American Journal of Obstetrics and Gynecology|December 3, 2014
Evaluation of strategies regarding management of imminent preterm delivery before 32 weeks of gestation: a regional cohort study among 1375 women in the NetherlandsMerel Boesveld, Martijn A Oudijk, Steven V Koenen, et al.
Journal of Clinical Medicine|October 28, 2023
Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort StudySapthami Nadesapillai, Femke Mol, Simone L Broer, et al.
BMC Pregnancy and Childbirth|March 5, 2014
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)Elvira Og van Vliet, Ewoud Schuit, Karst Y Heida, et al.
Lancet (London, England)|March 6, 2016
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trialElvira O G van Vliet, Tobias A J Nijman, Ewoud Schuit, et al.
Pageof 2